A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

January 31, 2015

Conditions

Lymphoma, Non-HodgkinLymphomaLymphomas: Non-Hodgkin Follicular / Indolent B-CellLymphomas: Non-Hodgkin

Interventions

DRUG

PF-3512676

18 mg injection

RADIATION

Local radiotherapy

2 gray (2 Gy) on each of Days 1 and 2

Trial Locations (1)

Stanford University School of Medicine, Stanford